Full text
Earnings transcript
Read the complete earnings call transcript.
ICL
ICL
ICL Group Ltd
$5.59
0
(0%)
| Exchange: | NYSE |
| Market Cap: | 7.215B |
| Shares Outstanding: | 1.2B |
Delayed data
About The Company
| Sector: | Basic Materials | |||||
| Industry: | Agricultural Inputs | |||||
| CEO: | Elad Aharonson | |||||
| Full Time Employees: | 12349 | |||||
| Address: |
| |||||
| Website: | https://www.icl-group.com |
ICL Group Ltd, a global enterprise specializing in the production of minerals and chemicals, conducts its operations through four distinct business units. The company, which originated as Israel Chemicals Ltd and adopted its current name in May 2020, was founded in 1968 and maintains its headquarters in Tel Aviv, Israel. The Industrial Products segment is responsible for extracting bromine from a byproduct solution generated during potash production, subsequently manufacturing bromine-based compounds. It also produces various grades of potash, salt, magnesium chloride, and magnesia products, alongside the creation and distribution of phosphorus-based flame retardants and other phosphorus derivatives. Within its Potash division, ICL sources potash from the Dead Sea, while simultaneously engaging in the mining and production of potash and salt. This segment is also a producer of Polysulphate, and it manufactures and markets magnesium and its alloys, along with associated by-products like chlorine and sylvinite. Additionally, it sells salt. The Phosphate Solutions segment converts foundational phosphate commodities into specialized products. It manufactures and distributes phosphate-based fertilizers, sulphuric acid, and green phosphoric acid. This unit also produces thermal phosphoric acid for a diverse array of industrial uses, spanning sectors such as oral hygiene, cleaning products, paints and coatings, water treatment, asphalt modification, construction, and metal treatment. Moreover, it develops and produces functional food ingredients and phosphate additives for application in the processed meat, poultry, seafood, dairy, beverage, and baked goods markets, as well as manufacturing milk and whey proteins for the broader food ingredients industry. Finally, the Innovative Ag Solutions (IAS) segment focuses on the development, manufacturing, marketing, and sale of fertilizers primarily composed of nitrogen, potash, and phosphate. This includes a spectrum of products such as water-soluble specialty, liquid, soluble, and controlled-release fertilizers. ICL Group’s diverse product portfolio reaches global markets through an established network of marketing firms, agents, and distributors.
Click to read more…
Revenue Segmentation
EPS
Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.
Earnings Call
AI summary
Key takeaways
Short, structured highlights from the call so you can focus on what matters.
Log in to continue
Log in to read the full transcript and AI-generated earnings summaries.
Login — it's freeIncome Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 7,536,000 | 6,841,000 | 7,153,000 |
| Gross Profit | 2,671,000 | 2,256,000 | 2,186,000 |
| EBITDA | 1,670,000 | 1,378,000 | 1,318,000 |
| Operating Income | 1,141,000 | 775,000 | 703,000 |
| Net Income | 647,000 | 407,000 | 226,000 |
(* All numbers are in thousands)
Balance Sheet
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total Assets | 11,627,000 | 11,321,000 | 12,413,000 |
| Total Liabilities | 5,590,000 | 5,334,000 | 6,170,000 |
| Total Stockholders Equity | 5,768,000 | 5,724,000 | 5,983,000 |
| Total Debt | 2,687,000 | 2,293,000 | 2,756,000 |
| Cash and Cash Equivalents | 420,000 | 327,000 | 291,000 |
(* All numbers are in thousands)
Cash Flow Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating Cash Flow | 1,595,000 | 1,468,000 | 954,000 |
| Capital Expenditure | -780,000 | -713,000 | -824,000 |
| Free Cash Flow | 815,000 | 755,000 | 130,000 |
| Net Income | 647,000 | 407,000 | 226,000 |
| Net Change in Cash | 3,000 | -93,000 | -36,000 |
(* All numbers are in thousands)
Analyst Estimates
| Fiscal Year | 2028 | Full Access | Full Access | Full Access | Full Access |
|---|---|---|---|---|---|
| Estimated Revenue (Low) | 8,106,294.907 | Full Access | Full Access | Full Access | Full Access |
| Estimated Revenue (High) | 8,308,709.558 | Full Access | Full Access | Full Access | Full Access |
| Estimated Revenue (Avg) | 8,230,073.430 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (Low) | 2,040,445.348 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (High) | 2,091,395.386 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (Avg) | 2,071,601.791 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (Low) | 598,251.648 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (High) | 617,764.626 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (Avg) | 610,184.137 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (Low) | 1,487,610.543 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (High) | 1,524,756.264 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (Avg) | 1,510,325.512 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (Avg) | 0.470 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (High) | 0.480 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (Low) | 0.460 | Full Access | Full Access | Full Access | Full Access |
| Number of Analysts (Estimated Revenue) | 1 | Full Access | Full Access | Full Access | Full Access |
| Number of Analysts (Estimated EPS) | 1 | Full Access | Full Access | Full Access | Full Access |
Log in to continue
Log in and subscribe to Full Access to see up to 5 years of analyst estimates.
Login — it's free(* All numbers are in thousands)
Current Key Metrics
Log in to continue
Log in to see all key valuation metrics and ratios for this symbol.
Login — it's freeForward P/E Ratios
Log in to continue
Log in with Full Access for forward P/E high/low estimates and the full multi-year table.
Login — it's freeSWOT Analysis
At what price to buy it? -
Intrinsic Value Calculator
Based on current fundamentals and analyst forecasts, MARKETSnap estimates ICL intrinsic value between $4.86 – $8.61 per share. This depends on revenue growth, margins, and discount rate.
This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.
[intrinsic_calculator]
Common questions about ICL valuation
Is ICL Group Ltd (ICL) overvalued or undervalued right now?
MARKETSnap estimates intrinsic value for ICL Group Ltd (ICL) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.
Is ICL a buy, hold, or sell for long-term investors?
MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether ICL trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.
What is ICL’s P/E ratio?
You can see ICL’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.
How is intrinsic value calculated for ICL?
MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.
Is ICL a good long-term investment?
Whether ICL fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.
ICL
1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.
Daily snapshot
0
Trading Metrics:
| Open: | 5.63 | Previous Close: | 5.59 | |
| Day Low: | 5.51 | Day High: | 5.68 | |
| Year Low: | 4.76 | Year High: | 7.35 | |
| Price Avg 50: | 5.78 | Price Avg 200: | 5.72 | |
| Volume: | 879418 | Average Volume: | 1.611M |
Log in to continue
Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.
Login — it's free
